ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000273123.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.025845488	Resistant
ENSG00000273123.1	ABT-263 (navitoclax)	Brain lower grade glioma	0.021225167	Resistant